Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9–22.
Google Scholar
Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883–92.
Google Scholar
Burtness B, Harrington KJ, Greil R, Soulieres D, Tahara M, de Castro G Jr., et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019;394:1915–28.
Google Scholar
Ferris RL, Licitra L, Fayette J, Even C, Blumenschein G Jr., Harrington KJ, et al. Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use. Clin Cancer Res. 2019;25:5221–30.
Google Scholar
Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.
Google Scholar
Rai P, Mahajan A. Radiomics in head and neck squamous cell carcinoma – a leap towards precision oncology. J Immunother Cancer. 2025;13:e011692.
Google Scholar
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749–62.
Google Scholar
Zwanenburg A, Vallieres M, Abdalah MA, Aerts H, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328–38.
Google Scholar
Traverso A, Wee L, Dekker A, Gillies R. Repeatability and reproducibility of radiomic features: a systematic review. Int J Radiat Oncol Biol Phys. 2018;102:1143–58.
Google Scholar
van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104–e7.
Google Scholar
Yuan Z, Ai S, He Q, Wu K, Yang M, Zheng K, et al. Intratumoral and peritumoral habitat radiomics of MRI predicts pathologic complete response to neoadjuvant chemoimmunotherapy in oral squamous cell carcinoma. Int J Surg. 2025;111:6232–44.
Google Scholar
Marcu DC, Grava C, Marcu LG. Current role of delta radiomics in head and neck oncology. Int J Mol Sci. 2023;24:2214.
Google Scholar
Trada Y, Keall P, Jameson M, Moses D, Lin P, Chlap P, et al. Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer. Eur Radiol. 2023;33:8788–99.
Google Scholar
Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285–9.
Google Scholar
Han JE, Diplas BH, Paudyal R, Oh JH, Shridhar AK, Aliotta E, et al. Apparent diffusion coefficient magnetic resonance imaging as a predictive biomarker for hypoxia, treatment de-escalation, and recurrence in human papillomavirus-associated oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2026;124:1015–23.
Google Scholar
Sorensen A, Carles M, Bunea H, Majerus L, Stoykow C, Nicolay NH, et al. Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2020;47:1056–64.
Google Scholar
Huang M, Law HKW, Tam SY. Use of radiomics in characterizing tumor hypoxia. Int J Mol Sci. 2025;26:6679.
Google Scholar
Nguyen TM, Bertolus C, Giraud P, Burgun A, Saintigny P, Bibault JE, et al. A radiomics approach to identify immunologically active tumor in patients with head and neck squamous cell carcinomas. Cancers (Basel). 2023;15:5369.
Google Scholar
Zheng YM, Yuan MG, Zhou RQ, Hou F, Zhan JF, Liu ND, et al. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma. Eur Radiol. 2022;32:5362–70.
Google Scholar
Jiang H, Zhou L, Zhang Q, Yu T, Yu Z. Radiomics-based prediction of T cell-inflamed gene expression profile and prognosis in head and neck squamous cell carcinoma. Med Phys. 2025;52:e18028.
Google Scholar
Zandberg DP, Zenkin S, Ak M, Mamindla P, Peddagangireddy V, Hsieh R, et al. Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients. Head Neck. 2025;47:129–38.
Google Scholar
Fan B, Fan B, Sun N, Zou H, Gu X. A radiomics model to predict gammadelta T-cell abundance and overall survival in head and neck squamous cell carcinoma. FASEB J. 2024;38:e23529.
Google Scholar
Keek S, Sanduleanu S, Wesseling F, de Roest R, van den Brekel M, van der Heijden M, et al. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. PLoS One. 2020;15:e0232639.
Google Scholar
Lin P, Xie W, Li Y, Zhang C, Wu H, Wan H, et al. Intratumoral and peritumoral radiomics of MRIs predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma. J Immunother Cancer. 2024;12:e009616.
Google Scholar
Wang CY, Ginat DT. Preliminary computed tomography radiomics model for predicting pretreatment CD8+ T-cell infiltration status for primary head and neck squamous cell carcinoma. J Comput Assist Tomogr. 2021;45:629–36.
Google Scholar
Rabasco Meneghetti A, Zwanenburg A, Linge A, Lohaus F, Grosser M, Baretton GB, et al. Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC. Sci Rep. 2022;12:16755.
Google Scholar
Corti A, Lenoci D, Corino VDA, Mattavelli D, Ravanelli M, Poli T, et al. Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma. Sci Rep. 2025;15:12622.
Google Scholar
Zwirner K, Hilke FJ, Demidov G, Socarras Fernandez J, Ossowski S, Gani C, et al. Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D. Strahlenther Onkol. 2019;195:771–9.
Google Scholar
Katsoulakis E, Yu Y, Apte AP, Leeman JE, Katabi N, Morris L, et al. Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma. Oral Oncol. 2020;110:104877.
Google Scholar
Wu L, Lin P, Zhao Y, Li X, Yang H, He Y. Prediction of genetic alterations in oncogenic signaling pathways in squamous cell carcinoma of the head and neck: radiogenomic analysis based on computed tomography images. J Comput Assist Tomogr. 2021;45:932–40.
Google Scholar
Rasmussen JH, Olin A, Lelkaitis G, Hansen AE, Andersen FL, Johannesen HH, et al. Does multiparametric imaging with (18)F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma? Br J Cancer. 2020;123:46–53.
Google Scholar
Vallieres M, Kay-Rivest E, Perrin LJ, Liem X, Furstoss C, Aerts H, et al. Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. Sci Rep. 2017;7:10117.
Google Scholar
Bogowicz M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, Pruschy M, Studer G, et al. Post-radiochemotherapy PET radiomics in head and neck cancer – The influence of radiomics implementation on the reproducibility of local control tumor models. Radiother Oncol. 2017;125:385–91.
Google Scholar
Franzese C, Lillo S, Cozzi L, Teriaca MA, Badalamenti M, Di Cristina L, et al. Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node-positive head and neck cancer. Head Neck. 2023;45:1184–93.
Google Scholar
Winter RM, Boeke S, Leibfarth S, Habrich J, Clasen K, Nikolaou K, et al. Clinical validation of a prognostic preclinical magnetic resonance imaging biomarker for radiotherapy outcome in head-and-neck cancer. Radiother Oncol. 2025;204:110702.
Google Scholar
Leger S, Zwanenburg A, Pilz K, Zschaeck S, Zophel K, Kotzerke J, et al. CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer. Radiother Oncol. 2019;130:10–7.
Google Scholar
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.
Google Scholar
Ma Q, Ren J, Wang R, Yuan Y, Tao X. Predicting response to immunotherapy in oral squamous cell carcinoma via a CT-based radiomics model. BMC Med Imaging. 2024;24:266.
Google Scholar
Sim Y, Sohn B, Kim S, Kim HR, Hong MH, Kim J, et al. Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma. Future Oncol. 2024;20:2869–78.
Google Scholar
Vos JL, Zuur CL, Smit LA, de Boer JP, Al-Mamgani A, van den Brekel MWM, et al. [(18)F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2022;49:2010–22.
Google Scholar
Shah H, Wang Y, Cheng SC, Gunasti L, Chen YH, Lako A, et al. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers. JAMA Otolaryngol Head Neck Surg. 2022;148:268–76.
Google Scholar
Navarro-Garcia D, Grussu F, Zatse C, Klumper N, Macarro C, Hernando-Calvo A, et al. Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response. J Immunother Cancer. 2025;13:e012143.
Google Scholar
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, et al. Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N Engl J Med. 2025;393:37–50.
Google Scholar
Pan Z, Men K, Liang B, Song Z, Wu R, Dai J. A subregion-based prediction model for local-regional recurrence risk in head and neck squamous cell carcinoma. Radiother Oncol. 2023;184:109684.
Google Scholar
Beddok A, Grogg K, Nioche C, Rozenblum L, Orlhac F, Calugaru V, et al. Predicting tumor recurrence site after reirradiation in head and neck cancer: a retrospective external validation of a published [18F]-FDG PET radiomic signature. Radiol Med. 2025;130:1854–63.
Google Scholar
Bang C, Gautier H, Le WT, Lalonde A, Bernard G, Markel D, et al. Dynamic prediction of Radiotherapy toxicities in Head and neck cancer using clinical and imaging data. Radiother Oncol. 2026;214:111312.
Google Scholar
Ugwu GC, Jalali F, Liu G, Li G, Langendijk JA, Alizadeh BZ. The actual performance of ML/AI models in predicting radiation-induced toxicity in head and neck cancer: a systematic review and meta-analysis. Radiother Oncol. 2026;216:111350.
Google Scholar
Lin YC, Lin G, Pandey S, Yeh CH, Wang JJ, Lin CY, et al. Fully automated segmentation and radiomics feature extraction of hypopharyngeal cancer on MRI using deep learning. Eur Radiol. 2023;33:6548–56.
Google Scholar
Choi Y, Bang J, Kim SY, Seo M, Jang J. Deep learning-based multimodal segmentation of oropharyngeal squamous cell carcinoma on CT and MRI using self-configuring nnU-Net. Eur Radiol. 2024;34:5389–400.
Google Scholar
Khajetash B, Hajianfar G, Talebi A, Mahdavi SR, Ghavidel B, Kalati FA, et al. Impact of harmonization on predicting complications in head and neck cancer after radiotherapy using MRI radiomics and machine learning techniques. Med Phys. 2025;52:5091–103.
Google Scholar
Orlhac F, Eertink JJ, Cottereau AS, Zijlstra JM, Thieblemont C, Meignan M, et al. A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies. J Nucl Med. 2022;63:172–9.
Google Scholar
Kazmierski M, Welch M, Kim S, McIntosh C, Rey-McIntyre K, Huang SH, et al. Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics. Cancer Res Commun. 2023;3:1140–51.
Google Scholar
Mohamed ASR, Abusaif A, He R, Wahid KA, Salama V, Youssef S, et al. Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study. Radiother Oncol. 2023;183:109641.
Google Scholar
Bae J, Mani K, Czerwonka L, Vanison C, Ryu S, Prasanna P. Spatial Radiomic Graphs for Outcome Prediction in Radiation Therapy-treated Head and Neck Squamous Cell Carcinoma Using Pretreatment CT. Radiol Imaging Cancer. 2025;7:e240161.
Google Scholar
Ma B, Guo J, De Biase A, van Dijk LV, van Ooijen PMA, Langendijk JA, et al. PET/CT based transformer model for multi-outcome prediction in oropharyngeal cancer. Radiother Oncol. 2024;197:110368.
Google Scholar
Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts H. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500–10.
Google Scholar
Fanizzi A, Comes MC, Bove S, Cavalera E, de Franco P, Di Rito A, et al. Explainable prediction model for the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma using CNN on CT images. Sci Rep. 2024;14:14276.
Google Scholar
